News

RotaFlash, June 2013

Three recent scientific studies from the U.S. Centers for Disease Control and Prevention demonstrate the powerful and real-world effectiveness of rotavirus vaccination in the US, the benefits of which extend beyond the health of infants and young children.

Read the full article

Scandinavian Biopharma, May 2013

Results from a clinical Phase I study of a novel vaccine against diarrhea caused by enterotoxigenic Escherichia coli (ETEC) found the vaccine was safe and well tolerated. ETEC is a common culprit of travelers' diarrhea, but it is also a major cause of diarrheal disease among children living in endemic countries. Future clinical studies will document the vaccine’s protective efficacy in travelers, and will study its safety and immunogenicity among children in ETEC-endemic areas.

Read the full press release.

Times of India, May 2013

A pivotal clinical study of India's first indigenous rotavirus vaccine found it to be safe and efficacious against severe rotavirus. A public-private partnership worked to develop the vaccine, which will provide an affordable addition to the global market.

Read the full article.

Washington Post, May 2013

A three-year, multi-country study designed to give researchers and public health officials a clearer picture of diarrheal disease burden found rotavirus to be the most common cause, followed by Cryptosporidium, Escherichia coli, and Shigella.

Read the full article.

RotaFlash, May 2013

A Phase III trial of a new rotavirus vaccine candidate from India demonstrates safety and efficacy. Additionally, a new study shows that rotavirus is the #1 cause of moderate-to-severe diarrhea in children less than two years old, underscoring the need for rotavirus vaccines.

Read the full article

Huffington Post, April 2013

David Winder, Chief Executive of WaterAid, notes that problems like unsafe drinking water, lack of sanitation, and poor hygiene are exacerbated by a lack of education about their health impact. He cites the new Global Action Plan against Pneumonia and Diarrhoea (GAPPD) as an ecnouraging example of increasing coordination and partnership that is designed to tackle the problems in locally-specific ways.

Read the full article

Rotaflash, April 2013

Following an announcement on April 27, Haiti will become the fifth and final GAVI-eligible country in the Americas region to introduce rotavirus vaccination, with support from the GAVI Alliance. Vaccines offer great promise to slash childhood deaths due to rotavirus, which claims 2,200 Haitian children each year—accounting for nearly half of all under-five diarrheal deaths in Haiti.

Read the full article.

The Guardian, April 2013

In highlighting the Integrated Global Action Plan for Pneumonia and Diarrhoea and accompanying scientific articles in the Lancet, the Guardian notes the coordinated effort required to apply a variety of interventions, from clean water to antibiotics to vaccines, to achieve the greatest impact on child health.

Read the full article.

UNICEF, April 2013

The newly launched Integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhoea (GAPPD) calls for closer integration of efforts to prevent and treat these two diseases and sets ambitious targets to reduce child deaths and increase access to life-saving interventions.

Read the full press release.

RotaFlash, March 2013

Mexico’s Ministry of Health and the US Centers for Disease Control and Prevention have just released data that shows signficant reduction in rates of diarrheal disease across all regions of Mexico after the introduction of the rotavirus vaccine.

Read the full article

Syndicate content